Commercialization and health economics and outcomes research (HEOR) strategies for therapeutics development are changing constantly, due to the current commercial success rate for pharma, biotech and medical device industries, as well as the often-referenced, looming patent cliff. Commercialization topics are covered in a wide range of webinars on this page – from pharmacoeconomics, access challenges and strategic alliances, to employing drug models to determine commercialization strategy.